Australia Ultrasound Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

Australia ultrasound devices market size in 2026 is estimated at USD 186.26 million, growing from 2025 value of USD 178.44 million with 2031 projections showing USD 230.84 million, growing at 4.38% CAGR over 2026-2031. This report is Segmented by Application (Anesthesiology, Cardiology, Gynecology/Obstetrics, Musculoskeletal, Radiology, and More), Technology (2D Ultrasound Imaging, 3D & 4D Ultrasound Imaging, and More), Portability (Stationary Systems, and More), and End User (Public Hospitals, Private Hospitals, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Units).

Australia Ultrasound Devices Market Trends and Insights

Burden of Chronic & Lifestyle Diseases

Chronic cardiovascular, musculoskeletal, and oncologic conditions are increasing alongside an aging population, heightening ultrasound demand in every state. AI-enhanced workflows now shorten scan-to-report times, crucial where sonographer shortages delay appointments. Mobile systems further support community screenings, reducing the need to refer patients for costly CT or MRI. As over-65 citizens are projected to rise 60% by 2030, scalable diagnostic capacity becomes a policy imperative. Vendors that bundle preventative-care training with equipment sales benefit from this demographic burden.

Rapid Adoption of POCUS in Primary Care & Ambulances

Point-of-care ultrasound is migrating from emergency departments to general practice. Rural clinicians who completed structured courses reported a 22% knowledge gain and 62% clinical utilisation within six months. The Northern Territory’s tele-sonography initiative links paramedics with hospital specialists via live video, proving lifesaving in obstetric emergencies. Despite clear utility, diffusion is tempered by practice cultures that prefer specialist referral and by reimbursement rules that still mandate on-site supervision for Medicare rebates.Evidence-generation studies underway aim to clarify billing pathways and further legitimise POCUS in primary settings.

Reimbursement Uncertainty for Handheld Scans

Medicare note IN.0.13 requires specialist supervision for many ultrasound rebates, leaving handheld POCUS scans by general practitioners unfunded outside hospital walls. This limits private adoption even where clinical benefit is proven. Private insurers have not yet standardised handheld coverage, instead approving claims case-by-case. Upcoming Health Technology Assessment reforms promise conditional funding pathways, but evidence dossiers and price-volume agreements will take time to assemble. For rural GPs, the absence of clear billing codes remains the chief obstacle to investment.

Other drivers and restraints analyzed in the detailed report include:

• Miniaturization & AI-Assisted Imaging Workflow
• Government “Buying Australian Made” Procurement Push
• Sonographer Workforce Shortages

Segment Analysis

Obstetrics and gynecology retained a 21.95% share of the Australia ultrasound devices market in 2025, reflecting universal antenatal screening guidelines and the popularity of 3D fetal imaging packages in private clinics. The segment continues to generate steady unit sales as expectant parents opt for elective 4D keepsake scans that require advanced transducers. Rising maternal age also drives high-risk screenings, favoring cart-based systems with sophisticated workflow modules.

Anesthesiology is forecast to expand at a 5.69% CAGR, the fastest among clinical uses, as regional-block techniques increasingly rely on ultrasound guidance for safety. Emergency departments and day-surgery centers are retrofitting procedure rooms with portable systems capable of vascular access, nerve mapping, and post-operative lung checks. The Australia ultrasound devices market size for anesthesiology is therefore set to climb more quickly than radiology purchases, though overall revenue remains smaller in absolute terms.

Three-dimensional and four-dimensional imaging captured 42.98% of the Australia ultrasound devices market size in 2025, benefiting from obstetric and cardiology demand for volumetric assessment and post-processing analytics. Vendors differentiate through ergonomic probe designs and real-time rendering, which shorten scan times.

High-intensity focused ultrasound commands just a niche share today but shows 5.19% CAGR potential thanks to non-invasive tumor ablation for uterine fibroids and prostate applications. Hospitals trialling HIFU note shorter patient recovery times versus surgery, indicating broader adoption once capital budgets align. Traditional 2D diagnostic systems will persist in rural settings because of low cost, but advanced modalities appear poised to capture incremental spend.

Complete Report Scope:

• By Application
  • Anesthesiology
  • Cardiology
  • Obstetrics & Gynecology
  • Musculoskeletal
  • Radiology
  • Critical Care
  • Urology
  • Vascular
  • Other Applications
• By Technology
  • 2D Ultrasound Imaging
  • 3D & 4D Ultrasound Imaging
  • Doppler Imaging
  • High-Intensity Focused Ultrasound
  • Other Technologies
• By Portability
  • Stationary Systems
  • Portable Cart-based Systems
  • Hand-held / Pocket Devices
• By End User
  • Public Hospitals
  • Private Hospitals
  • Specialist Clinics
  • Other End Users

List of Companies Covered in this Report:

• GE Healthcare
• Koninklijke Philips
• Siemens Healthineers
• Canon
• FUJIFILM
• Samsung Group
• Mindray Medical
• Esaote
• Hologic
• SonoScape
• Hitachi
• Nanosonics
• Clarius Mobile Health
• Butterfly Network
• BenQ Medical
• B-K Medical
• Terason
• Supersonic Imagine
• Telemed
• Shenzhen Lifotronic

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support